The Demerol (Meperidine) Market report is equipped with market data from 2013 to 2023. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2018 to 2023. The detailed sales channel is also covered in the study.
Demerol (meperidine), chemically known as ethyl 1-methyl-4-phenylisonipecotate hydrochloride, is an opioid pain medication. Meperidine is used to treat moderate-to-severe pain.
Scope of the Report:
This report focuses on the Demerol (Meperidine) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
An opioid is sometimes referred to as narcotics. Opioids are drugs that act on the nervous system to relieve pain. The term opioid refers to all substances (exogenous or endogenous) with morphine-like properties.
The worldwide market for Demerol (Meperidine) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017.
Market Segment by Manufacturers, this report covers
- Purdue Pharma
- Egalet
- Boehringer Ingelheim
- Janssen
- Sanofi
- Sun Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Endo Pharmaceuticals
- Actavis
- Pfizer
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Anesthesia
- Cough Treatment
- Diarrhea Treatment
There are 15 Chapters to deeply display the global Demerol (Meperidine) market.
Chapter 1, to describe Demerol (Meperidine) Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Demerol (Meperidine), with sales, revenue, and price of Demerol (Meperidine), in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Demerol (Meperidine), for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Demerol (Meperidine) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Demerol (Meperidine) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source